Corcept Therapeutics (CORT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
69.59 +2.16 (+3.20%) 04/15/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 70.99 +1.40 (+2.01%) 16:14 ET
for Tue, Apr 15th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CORT | MDGL | STVN | ||
| Company | Corcept Therapeutics | Madrigal Pharmaceuticals Inc | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 67.43 | 324.44 | 22.50 | ||
| High | 70.37 | 330.64 | 22.64 | ||
| Low | 67.42 | 314.74 | 21.98 | ||
| Last | 69.59 | 321.10 | 22.64 | ||
| Change | +2.16 | -1.22 | +0.28 | ||
| % Change | +3.20% | -0.38% | +1.25% | ||
| Volume | 1,291,000 | 195,800 | 269,700 | ||
| 20-Day Average Volume | 2,398,135 | 301,660 | 357,940 | ||
| Previous Close | 67.43 | 322.32 | 22.36 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 69.79 | 326.63 | 20.90 | ||
| 20-Day Raw Stochastic | 24.87% | 51.41% | 92.53% | ||
| 20-Day Relative Strength | 51.68% | 48.44% | 57.88% | ||
| Weighted Alpha | +127.38 | +14.42 | -5.91 | ||
| Today's Opinion | 88% Buy | 24% Buy | 72% Buy | ||
| Previous Opinion | 88% Buy | 24% Buy | 72% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.28% since 04/08/25 | +6.05% since 04/08/25 | +21.92% since 04/08/25 | ||
| Low | 64.62 on 04/09/25 | 289.99 on 04/09/25 | 18.18 on 04/09/25 | ||
| High | 75.08 on 04/09/25 | 333.32 on 04/09/25 | 22.64 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | +24.25% since 03/14/25 | -7.82% since 03/14/25 | +13.03% since 03/14/25 | ||
| Low | 53.79 on 03/28/25 | 289.99 on 04/09/25 | 18.18 on 04/09/25 | ||
| High | 117.33 on 03/31/25 | 350.50 on 03/25/25 | 23.00 on 03/24/25 | ||
| 3-Month | |||||
| %Chg | +29.40% since 01/15/25 | +17.01% since 01/15/25 | +2.21% since 01/15/25 | ||
| Low | 52.45 on 03/07/25 | 266.52 on 01/16/25 | 17.81 on 03/03/25 | ||
| High | 117.33 on 03/31/25 | 377.46 on 02/26/25 | 23.65 on 01/21/25 | ||
| 6-Month | |||||
| %Chg | +48.57% since 10/15/24 | +48.54% since 10/15/24 | +22.64% since 10/15/24 | ||
| Low | 42.01 on 10/31/24 | 200.63 on 10/23/24 | 17.12 on 10/25/24 | ||
| High | 117.33 on 03/31/25 | 377.46 on 02/26/25 | 24.90 on 12/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,114,067 | 7,116,823 | 6,771,570 | ||
| Shares Outstanding, K | 105,503 | 22,080 | 302,843 | ||
| Annual Sales | 675,040,000 | 180,130,000 | 1,194,680,000 | ||
| Annual Net Income | 141,210,000 | -465,890,000 | 127,450,000 | ||
| Last Quarter Sales | 181,890,000 | 103,320,000 | 353,380,000 | ||
| Last Quarter Net Income | 30,750,000 | -59,420,000 | 51,800,000 | ||
| 60-Month Beta | 0.15 | -0.69 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.26 on 02/26/25 | -2.71 on 02/26/25 | 0.20 on 03/06/25 | ||
| Latest Earnings Date | 05/07/25 | 05/06/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 55.34 | 0.00 | 42.13 | ||